MY142617A - Dual specific ligands with increased serum half-life - Google Patents
Dual specific ligands with increased serum half-lifeInfo
- Publication number
- MY142617A MY142617A MYPI20045336A MY142617A MY 142617 A MY142617 A MY 142617A MY PI20045336 A MYPI20045336 A MY PI20045336A MY 142617 A MY142617 A MY 142617A
- Authority
- MY
- Malaysia
- Prior art keywords
- life
- serum half
- increased serum
- specific ligands
- dual specific
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
THE INVENTION PROVIDES A DUAL-SPECIFIC LIGAND CORNPNSMQ A FIRST IMMUNOGLOBULIN VARIABLE DOMAIN HAVING A FIRST BINDING SPECIFICITY AND A COMPLEMENTARY OR NON-COMPLEMENTARY IMMUNOGLOBULIN VARIABLE DOMAIN HAVING A SECOND BINDING SPECIFICITY.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20045336 MY142617A (en) | 2004-12-23 | 2004-12-23 | Dual specific ligands with increased serum half-life |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20045336 MY142617A (en) | 2004-12-23 | 2004-12-23 | Dual specific ligands with increased serum half-life |
Publications (1)
Publication Number | Publication Date |
---|---|
MY142617A true MY142617A (en) | 2010-12-15 |
Family
ID=44256609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20045336 MY142617A (en) | 2004-12-23 | 2004-12-23 | Dual specific ligands with increased serum half-life |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY142617A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11773159B2 (en) | 2011-05-05 | 2023-10-03 | Merck Patent Gmbh | Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same |
-
2004
- 2004-12-23 MY MYPI20045336 patent/MY142617A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11773159B2 (en) | 2011-05-05 | 2023-10-03 | Merck Patent Gmbh | Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070081A1 (en) | Dual specific ligands with increased serum half-life | |
EA020464B9 (en) | Antibody single variable domains against serum albumin | |
WO2004058821A3 (en) | Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand | |
DE60237282D1 (en) | DOUBLE-SPECIFIC LIGAND AND ITS USE | |
WO2009058383A3 (en) | Ligand | |
WO2005086775A3 (en) | Lumen-exposed molecules and methods for targeted delivery | |
WO2008048970A3 (en) | Synthetic antibodies | |
WO2006130374A3 (en) | Tweak binding antibodies | |
WO2005047314A3 (en) | Fgf-beta binding and supported peptides | |
TW200738750A (en) | Ligands and methods of use therefor | |
AP2353A (en) | 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands. | |
DE60332774D1 (en) | IMPROVED SSO7 POLYMERASE CONJUGATE PROTEINS | |
WO2005069994A3 (en) | Folate conjugates and complexes | |
WO2009140039A3 (en) | Synthetic antibodies | |
WO2007026972A3 (en) | Binding protein molecule | |
ATE317126T1 (en) | LIGANDS FOR DETECTING PRIONS | |
MY142617A (en) | Dual specific ligands with increased serum half-life | |
WO2005019431A3 (en) | Selective inhibition of toll-like receptor-2 | |
CY1111435T1 (en) | DOUBLE-SPECIAL CONNECTOR AND USE OF IT | |
FR2865166B1 (en) | SLIDING AND SLIDING VEHICLE SEAT FOR SUCH A SEAT. | |
WO2003091415A3 (en) | Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color | |
WO2003057732A3 (en) | Multispecific binding molecules | |
WO2007072022A3 (en) | Composition comprising an antigen-recognizing molecule and a lipid-based carrier | |
WO2001061352A3 (en) | Production of a protein biosensor with a defined binding matrix | |
AU2004903907A0 (en) | Novel CGRP ligands |